← Leaderboards
Robert Paul Thomen
University Of Missouri-Columbia
$2,382,115
Attributed
$2,382,115
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $461.1K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,382,115 · 2
By mechanism
R01$2,382,115 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Guangfu Li$3,084,117
- Tae Hoon Kim$1,372,096
- Martin M Matzuk$44,230,622
- Ov D Slayden$15,947,398
- Wipawee Winuthayanon$2,727,306
Others in their field
Other Emerging Leaders on “Inhalation”
- Prasant Mohapatra · University Of California At Davis$54,024,752
- Leslie C. Sherwood · University Of Louisville$8,306,360
- Elizabeth Ann Sugar · Johns Hopkins University$6,288,276
- Bryce Beverlin II · Quench Medical, Inc.$5,631,185
- Thomas Dick · Rbhs-New Jersey Medical School$5,394,832
- Hossam Shaltout · Wake Forest University Health Sciences$5,054,042
Research focus
InhalationMagnetismImageImproved OutcomeLungMagnetic Resonance ImagingEosinophilic AsthmaGasesImaging TechniquesImpairmentAirway HyperresponsivenessBiological MarkersCostBiological Response Modifier TherapyAsthmaAirway InflammationAsthmaticBolus InfusionAsthmatic PatientBronchodilationBronchodilator AgentsAffectBiologicalMaps
Grant awards (6)
Assessment of Dissolved Phase 129Xe as a Biomarker for gas-exchange and vascular function in asthma$461,115
R01 · FY2025 · HL · contact PI
Hyperpolarized xenon MRI in treatment of severe asthma by mepolizumab: toward earlier detection of individual patient responses$387,500
R01 · FY2024 · HL · contact PI
Hyperpolarized xenon MRI in treatment of severe asthma by mepolizumab: toward earlier detection of individual patient responses$387,500
R01 · FY2023 · HL · contact PI
Hyperpolarized xenon MRI in treatment of severe asthma by mepolizumab: toward earlier detection of individual patient responses$387,500
R01 · FY2022 · HL · contact PI
Hyperpolarized xenon MRI in treatment of severe asthma by mepolizumab: toward earlier detection of individual patient responses$387,500
R01 · FY2021 · HL · contact PI
Hyperpolarized xenon MRI in treatment of severe asthma by mepolizumab: toward earlier detection of individual patient responses$371,000
R01 · FY2020 · HL · contact PI